Drug concentrations in neuropsychiatry. Methodological pitfalls: the influence of experimental design on results.
The valid study of relationships between pharmacokinetic measurements and clinical effects of psychotropic drugs depends on: (i) analytical methods for the drugs; (ii) the fluid assessed and pharmacokinetic derivations; (iii) clinical assessments and the nature of psychiatric illness; and (iv) statistical work. Standard problems with analytical methods include lack of specificity, unjustified claims for sensitivity, and failure to recognize metabolites as potential analytical contaminants and compounds for separate study. Problems with pharmacokinetic derivations include inappropriate calculations and incorrect assignment of terms such as 'half-life'. Clinical difficulties mostly relate to variations between patient groups, selection procedures and rating methods, and to timing of samples. Statistical controversies concern the calculation of metabolite ratios, pooling of data from drugs and their metabolites, and abuse of statistical techniques. These methodological problems are illustrated by reference to work with phenothiazines, tricyclic antidepressants, lithium, benzodiazepines and anticonvulsants.
D001826:Body Fluids / Q000032:analysis; D006801:Humans; D007700:Kinetics; D001523:Mental Disorders / Q000188:drug therapy; D004364:Pharmaceutical Preparations / Q000097:blood / Q000378:metabolism*; D012107:Research Design; D013223:Statistics as Topic
D004364:Pharmaceutical Preparations